Pivotal bioVenture Partners

Pivotal bioVenture Partners is a $300 million life sciences venture capital fund. We invest in privately held North American and European companies focused on innovative therapeutic products and platforms to address major unmet medical needs. We invest at all stages in a company’s evolution, from company creation through mid and late-stage clinical development. We are capable of leading or co-leading transactions and employ a rigorous investment review process that distinguishes us and helps us with syndicate building and positioning companies well for a future public offering or M&A event.